Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jui-Che Chen

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Venues

American journal of hematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, Feng-Ming Tien, Yuan-Yeh Kuo, Wan-Hsuan Lee, Yen-Ling Peng, Ming-Chih Liu, Mei-Hsuan Tseng, Cheng-An Hsu, Jui-Che Chen, Liang-In Lin, Hsun-I Sun, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia. American journal of hematology (2023)
Wan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Yi-Tsung Yang, Jui-Che Chen, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Liang-In Lin, Wen-Chien Chou, Chien-Chin Lin, Hsin-An Hou, Hwei-Fang Tien
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification. Blood cancer journal 13 (1) (2023)
Min-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, Feng-Ming Tien, Yuan-Yeh Kuo, Wan-Hsuan Lee, Yen-Ling Peng, Ming-Chih Liu, Mei-Hsuan Tseng, Cheng-An Hsu, Jui-Che Chen, Liang-In Lin, Hsun-I Sun, Yi-Kuang Chuang, Bor-Sheng Ko, Jih-Luh Tang, Ming Yao, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia. American journal of hematology (2023)

Jui-Che Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jui-Che Chen